Oragenics, Inc.
(NYSE Amex Equities : OGEN)

( )
OGEN After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson -0.26%165.190.7%$1305.30m
LLYEli Lilly & Co. 0.57%331.781.1%$1072.82m
ABBVAbbVie, Inc. 0.94%143.331.9%$877.03m
PFEPfizer Inc. -0.47%44.250.9%$815.29m
BMYBristol-Myers Squibb Co. 0.34%71.451.0%$767.68m
MRKMerck & Co., Inc. 0.01%88.400.7%$706.05m
AZNAstraZeneca Plc -0.54%56.731.0%$402.73m
ALNYAlnylam Pharmaceuticals, Inc. -0.11%201.028.2%$225.00m
GSKGSK Plc -1.01%30.400.3%$210.45m
NVSNovartis AG -1.11%77.360.2%$209.93m
IDXXIDEXX Laboratories, Inc. 0.44%350.123.9%$189.64m
GBTGlobal Blood Therapeutics, Inc. 0.00%68.495.4%$183.92m
HZNPHorizon Therapeutics Plc 1.35%67.055.4%$182.38m
NVONovo Nordisk A/S 0.63%106.040.1%$132.75m
SRPTSarepta Therapeutics, Inc. -0.76%110.6212.4%$132.70m

Company Profile

Oragenics, Inc. is a biopharmaceutical company, which focuses on the development of novel antibiotics and treatments against infectious disease and oral mucositis. Its technology and pipeline is comprised of antibiotics and genetically engineered bacterial strains. The company was founded by Jeffrey D. Hillman and Robert T. Zahradnik in November 1996 and is headquartered in Tampa, FL.